ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$5.050
+$0.030 (+0.60%)
Day Range
$4.900 - $5.090
52 Week Range
$0.605 - $5.240
Volume
411.37K
Avg Volume (10D)
471.98K
Market Cap
$806.99M
Price Chart
Market Statistics
Open$4.980
Previous Close$5.020
Day High$5.090
Day Low$4.900
52 Week High$5.240
52 Week Low$0.605
Valuation
Market Cap806.99M
Shares Outstanding159.80M
Price to Book8.93
Trading Activity
Volume411.37K
Value Traded2.06M
Bid$4.830 × 175
Ask$5.050 × 11,406
Performance
1 Day0.60%
5 Day13.48%
13 Week62.90%
52 Week596.55%
YTD7.22%
Technical Indicators
RSI (14)70.98
50-Day SMA$3.761
200-Day SMA$3.230
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
